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ABSTRACT
Oligonucleotide-mediated gene targeting is emerg-
ing as a powerful tool for the introduction of subtle
gene modifications in mouse embryonic stem (ES)
cells and the generation of mutant mice. However,
its efficacy is strongly suppressed by DNA mis-
match repair (MMR). Here we report a simple
and rapid procedure for the generation of mouse
mutants using transient down regulation of the
central MMR protein MSH2 by RNA interference.
We demonstrate that under this condition, unmodi-
fied single-stranded DNA oligonucleotides can
be used to substitute single or several nucleotides.
In particular, simultaneous substitution of four
adjacent nucleotides was highly efficient, providing
the opportunity to substitute virtually any given
codon. We have used this method to create a codon
substitution (N750F) in the Rb gene of mouse ES
cells and show that the oligonucleotide-modified
Rb allele can be transmitted through the germ line
of mice.
INTRODUCTION
Publication of the human genome sequence has opened
a whole new area of genetic research. In the last decade,
many locus-speciﬁc mutation databases have been con-
structed and made publicly available. For instance, the
IARC p53 database contains information on 21 587 somatic
mutations found in the human p53 gene (http://www-p53.
iarc.fr). Site-speciﬁc modiﬁcation of the mouse genome
provides a powerful tool to functionally characterize the
identiﬁed mutations and distinguish between polymorphisms
and truly pathogenic mutations. However, current strategies
based on homologous recombination require the design and
construction of a targeting vector and multiple rounds of
selection and clonal puriﬁcation of modiﬁed cells, which
are laborious and time-consuming (1). An alternative appro-
ach could be the introduction of subtle gene modiﬁcations
into the mouse genome by single-stranded DNA oligonu-
cleotides (2).
Numerous reports have shown that oligonucleotides that
differ from the target locus by one or a few nucleotides can
be used to introduce speciﬁc mutations into both episomally
and chromosomally located genes (3–6). In most cases,
chemically modiﬁed RNA–DNA chimeric oligonucleotides
or single-stranded DNA oligonucleotides were used in
which the chemical modiﬁcations served to protect the
oligonucleotides from nucleolytic degradation. The mecha-
nism of transfer of genetic information from the oligo-
nucleotide to the target remains largely elusive. Many
different cellular processes such as transcription (7,8), DNA
replication (9), homologous recombination (10) and DNA
mismatch repair (MMR) (11,12) seem to be involved. Several
reports have noticed that cells targeted by chemically modi-
ﬁed oligonucleotides underwent a G2 arrest that precluded
their clonal expansion (13,14).
In mouse embryonic stem (ES) cells, oligonucleotide-
mediated gene targeting frequencies appeared to be relatively
low. Chemically modiﬁed oligonucleotides showed targeting
frequencies that were  50-fold lower in ES cells than in
CHO-K1 cells (3,15). Overexpression of the Redb protein
from bacteriophage lambda seemed to increase the targeting
efﬁciency in ES cells, although the effect was not quantiﬁed
(16). To date, none of these approaches have been followed
up by experiments to show modiﬁcation of an endogenous
gene in ES cells and transmission of a modiﬁed allele through
the mouse germ line.
Previously, we demonstrated that the efﬁciency of gene
targeting by non-chemically modiﬁed single-stranded DNA
oligonucleotides in mouse ES cells is strongly suppressed
by the MMR system (11). In eukaryotic cells, DNA mis-
matches are recognized by MSH2 and its binding partners
MSH3 and MSH6 (17). The MSH2/MSH6 heterodimer
mainly recognizes single base substitutions and small loops
of 1 or 2 nt, while the MSH2/MSH3 complex has more
afﬁnity for larger loops of unpaired bases (18,19). We
showed that oligonucleotide-directed substitution, insertion
or deletion of a few nucleotides was only effective in cells
lacking the central MMR gene Msh2. However, the mutator
phenotype associated with MMR deﬁciency (20) may
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doi:10.1093/nar/gkl896lead to inadvertent genetic alterations on top of the
oligonucleotide-mediated modiﬁcation, hampering general
application of oligonucleotide-mediated targeting.
Here we show that transient suppression of MSH2 by RNA
interference allows effective oligonucleotide-mediated gene
modiﬁcation in wild-type mouse ES cells. Our method is gen-
erally applicable and provides the opportunity to modify in
principle any given codon in the ES cell genome. The occur-
rence of frameshift mutations at simple sequence repeats was
assessedtogaininsightintothelevelofspontaneousmutagene-
sis resulting from transient MSH2 suppression. We have suc-
cessfully applied the MSH2 knockdown strategy to substitute
a codon in the Rb gene (N750F) of MMR-proﬁcient ES cells
and used these cells to generate the ﬁrst mutant mouse line
that was created via oligonucleotide-mediated gene targeting.
METHODS
Cell culture and transfection
We developed two selectable targeting reporter systems
consisting of mutant neomycin genes (Figures 1a and 2a)
(11). A single copy of these mutant reporter genes was stably
integrated into the Rosa26 locus of Msh2
 / , Msh2
+/ ,
Msh3
 / , Msh6
 /  and wild-type ES cell lines as described
previously (11,20,21). ES cells (E14) were originally derived
from 129Ola and cultured in Glasgow minimal essential
medium (GMEM) supplemented with 10% fetal calf
serum, sodium pyruvate, non-essential amino acids, 1 mM 2-
mercaptoethanol and 1000 U/ml of leukemia inhibitory factor.
For transfection, ES cells were seeded onto gelatine-coated
six-well plates at a density of 7 · 10
5 per well in BRL-
conditioned medium. The next day, cells were exposed to
3 mg of oligonucleotide per well using 27 ml of TransFast 
transfection agent (Promega) as described before (11). For
transient down regulation of MSH2, wild-type or Msh2
+/ 
ES cells were ﬁrst transfected with 3 mg of pS-MSH2 using
27 ml TransFast  in 1.4 ml of serum-free medium. After
75 min of exposure to the transfection mixture, 4 ml of
(serum-containing) BRL-conditioned medium was added.
The cells were incubated overnight and then refed with
BRL-conditioned medium containing 20 mg/ml of puromycin
(Sigma-Aldrich). After 2 days, cells were washed with PBS,
trypsinized and seeded at a density of 7 · 10
5 cells per well.
The next day (day 1, Figure 3), cells were transfected with
3 mg of oligonucleotide as described before (11). The next
day, cells were counted and reseeded in selective medium
containing 750 mg/ml (Target 2) or 600 mg/ml (Target 1) of
G418 (Invitrogen-GIBCO). After 10 days, the number of
G418-resistant colonies was counted. For the Rb
N750F muta-
tion, targeted ES cells were expanded and plated in pools
of 5000 cells per well onto four 96-well feeder plates con-
taining irradiated mouse embryonic ﬁbroblasts (MEFs). In
three subsequent screening rounds, cells were seeded onto
96-well MEF feeder plates in pools of 100, 10 and 1 cells
per well, respectively. All oligonucleotides, deprotected and
desalted, were obtained from Sigma-Genosys Ltd.
RNA interference
We used the pSUPER vector containing a puromycin
resistance gene for expression of shRNAs in murine ES
cells (22). A 19 nt sequence corresponding to nucleotides
1231–1249 of the Msh2 gene (GenBank accession no.
NM_008628), separated from the reverse complement of
the same 19 nt sequence by a 9 nt non-complementary spacer
(TTCAAGAGA), was inserted into the pSUPER vector
(pS-MSH2). An empty vector with no gene-speciﬁc 19 nt
sequence served as a non-silencing control (pS).
Western blot analysis
Cells were lysed in a buffer containing 60 mM Tris–HCl
pH 6.8, 2% (w/v) SDS, 10% glycerol, 100 mM DTT and
bromophenolblue. Protein extracts from 2 · 10
5 ES cells
were separated by 7.5% SDS–PAGE and transferred to nitro-
cellulose membrane. Rabbit polyclonal antibodies against
MSH2 (1:500) (23), MSH3 (kindly provided by G. Crouse;
1:500) and MSH6 (1:500) (21) were used as primary anti-
bodies, and peroxidase-conjugated goat anti-rabbit IgG
(BioSource International) was used as a secondary antibody.
Signals were visualized with enhanced chemiluminescence.
Frameshift mutations at simple sequence repeats
We constructed two reporter cell lines consisting of a neo
gene containing either a (G)10 or a (CA)15C repeat disrupting
the open reading frame. The neo gene was derived from
plasmid pMC1neo (24) in which the sequence between the
ﬁrst and the ﬁfth codon was replaced by either a (G)10 or a
(CA)15C repeat. The pMC1-(CA)15C-neo gene was placed
immediately downstream of the promoterless histidinol-
resistance gene in a Rosa26 targeting vector (11). The
pMC1-(G)10-neo gene was inserted into the Rb targeting
vector 129Rb-his which is based on 129Rb-hyg (25).
These targeting vectors were subsequently introduced into
Msh2
 / , Msh2
+/  and wild-type ES cell lines by electropo-
ration (25) to insert single copies of the (CA)15C and G10
reporters into Rosa26 and Rb locus, respectively.
Msh2
 / , Msh2
+/  and wild-type cell lines containing the
selectable slippage reporters were transfected with 3 mgo f
pS or pS-MSH2 followed by selection with puromycin for
2 days. After 7 days of cell culture, 10
5 Msh2
 /  cells and
4 · 10
6 wild-type or Msh2
+/  cells were plated onto two
100 mm dishes in selective medium containing 600 mg/ml
G418. After 10 days, the number of resistant colonies was
counted.
Spontaneous mutation frequency at Hprt locus
Msh2
 / , Msh2
+/  and wild-type ES cell lines were trans-
fected with 3 mg of pS or pS-MSH2 followed by selection
with puromycin for 2 days. After 7 days of cell culture,
4 · 10
6 cells were plated onto two or seven 150 mm dishes
in selective medium containing 10 mg/ml 6-thioguanine
(Sigma-Aldrich). After 10 days, the number of resistant
colonies was counted.
PCR-based detection of Rb
N750F mutation
A 738-bp product was ampliﬁed by PCR using primers 1 and
2 (Figure 4a) in a reaction mixture containing genomic DNA
isolated from 2.5 · 10
4 ES cells, 1.25 U Taq polymerase,
1·PCR buffer containing 1.6 mM MgCl2, 12.5 pmol of
each primer and 0.2 mM dNTPs in a total volume of 25 ml.
After an initial denaturation step of 94 C for 5 min,
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60 C for 1 min, 72 C for 1 min 30 s and a ﬁnal elongation
step of 72 C for 10 min.
Similarly, a nested mutation-speciﬁc PCR was carried out
with primers 3/4 or primers 5/6 (Figure 4b) using 1 ml of the
ﬁrst PCR and an annealing temperature of 58 C.
Sequence analysis of Rb mRNA
Total RNA was isolated from Rb
+/N750F ES cells using RNA-
Bee  Total RNA Isolation Reagent (Campro Scientiﬁc).
Rb cDNA was prepared by reverse transcription using a
primer in exon 23 (primer 2). From this template, a 207 bp
product spanning the oligonucleotide-mediated modiﬁcation
was ampliﬁed by PCR using primers in exon 21 (primer 1)
and exon 23 (primer 4). This PCR product was cloned into
the pGEM -T Easy vector (Promega). Vector primers T7
and SP6 were used for sequencing.
RESULTS
Oligonucleotide-mediated targeting is suppressed
by DNA MMR
To provide a simple in vivo readout for the efﬁcacy of
oligonucleotide-mediated gene modiﬁcation, we have previ-
ously developed two selectable reporter gene systems consist-
ing of mutant neomycin resistance genes (neo) (11). The neo
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Figure 1. Oligonucleotide-mediated base substitution. (a) A single copy of a defective neomycin gene (neo) carrying an T to A point mutation in the start codon
(Target 2) was inserted into the Rosa26 locus of Msh2
 / , Msh3
 / , Msh6
 / , Msh2
+/  and wild-type ES cells. Upper case indicates codons. (b) Activity of the
neo gene can be restored by single-stranded DNA oligonucleotides that substitute 1–4 nt to create a new ATG start codon (mismatching bases are indicated in
red). Upper case indicates codons. (c) The efficiency of oligonucleotide-mediated base substitution in Msh3
 /  (red bars), Msh6
 /  (blue bars) and pS-MSH2
transfected wild-type (green bars) or Msh2
+/  (orange bars) ES cells is the number of G418-resistant colonies per 10
5 cells that were plated after exposure to the
oligonucleotides. Targeting data of Msh2
 /  (black bars) and wild-type (white bars) ES cells are taken from Ref. (26) and shown as controls. For each
oligonucleotide, the mean value is given of at least three independent experiments. Error bars show standard deviation. * P < 0.001, **P < 0.05 as compared with
untreated wild-type cells (Student’s t-test).
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(ATG ! AAG) in the start codon (Target 2, Figure 1a), or
a 2 bp insertion (extra GT) immediately after the start
codon, causing a frameshift mutation (Target 1, Figure 2a).
A single copy of these mutant reporter genes was stably
integrated into the Rosa26 locus of Msh2
 /  and wild-type
ES cells. Correction of the mutant sequence by oligonu-
cleotides restores the open reading frame (Target 1) or gener-
ates an ATG start codon (Target 2) resulting in G418
resistance.
As we have previously shown, G418-resistant colonies
were readily obtained in Msh2
 /  cells, but not in wild-
type cells, indicating that MMR activity imposes a strong
barrier to oligonucleotide-mediated gene targeting (11,26).
Transient down regulation of MSH2
The necessity of MMR deﬁciency greatly restricts the applica-
tion of oligonucleotide-mediated gene targeting for the gen-
eration of mutant mice. In order to establish a generally
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Figure 2. Oligonucleotide-mediated base insertion. (a) A single copy of a defective neomycin gene (neo) carrying a GT insertion behind the start codon (target 1)
was inserted into the Rosa26 locus of Msh2
 / , Msh6
 / , Msh2
+/  and wild-type ES cells. Upper case indicates codons. (b) Activity of the neo gene can be
restored by single-stranded DNA oligonucleotides inserting either 1 or 4 nt to regenerate the open reading frame (inserted bases are shown in red). Upper case
indicates codons. (c) The efficiency of oligonucleotide-mediated base insertion in Msh6
 /  (blue bars) and pS-MSH2 transfected wild-type (green bars) or
Msh2
+/  (orange bars) ES cells is the number of G418-resistant colonies per 10
5 cells that were plated after exposure to the oligonucleotides. Targeting data of
Msh2
 /  (black bars) and wild-type (white bars) ES cells are taken from Ref. (26) and shown as controls. For each oligonucleotide, the mean value is given of at
least three independent experiments. Error bars show standard deviation. * denotes P < 0.001 as compared with untreated wild-type cells (Student’s t-test).
 
 
 
Figure 3. MMR protein levels after MSH2 suppression. Western blot analysis
of wild-type ES cells transfected with pS-MSH2 followed by puromycin
selection for 2 days. Whole-cell extracts were analyzed for MSH2, MSH3 and
MSH6 for six consecutive days. Whole-cell extracts of Msh2
 /  cells were
used as negative control. WT, wild-type cells not treated with pS-MSH2;
Asteriskindicatesnon-specific band;l.c., non-specific bandasloadingcontrol.
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geting in ES cells, we minimized the inadvertent effects
of constitutive MMR deﬁciency by down regulating MMR
activity in wild-type ES cells for only a brief period. For
this purpose, we used the pSUPER vector containing a
puromycin resistance gene to transiently express a short
hairpin RNAi sequence against Msh2 mRNA (pS-MSH2)
(22). After transfection of wild-type ES cells with pS-
MSH2 and puromycin selection for 2 days, protein samples
were taken for six consecutive days and analyzed by
immunoblotting. MSH2 protein levels were 10-fold reduced
for 3 days, and then gradually increased back to wild-type
levels (Figure 3). This level of reduction was highly repro-
ducible and also obtained in Msh2
+/  ES cells (data not
shown). We also analyzed MSH3 and MSH6 protein levels
after pS-MSH2 transfection, since the stability of these
proteins is known to be dependent on their interaction
with MSH2 (20,21). Although both MSH3 and MSH6
protein levels were reduced upon down regulation of
MSH2 (Figure 3), low levels of these proteins were present.
This indicates that residual MSH2/MSH3 and MSH2/MSH6
complexes could still be formed in MSH2 knockdown
cells.
Nucleotide substitutions in MSH2 knockdown ES cells
We next investigated whether transient down regulation of
MSH2 rendered cells permissive for nucleotide substitutions
by oligonucleotides. Wild-type ES cells were transfected with
pS-MSH2 and cultured in the presence of puromycin for
2 days. pS-MSH2 containing cells were transfected with
different oligonucleotides to substitute 1, 2, 3 or 4 nt in the
mutated neo reporter gene (Figure 1b).
For the majority of substitution oligonucleotides, transient
down regulation of MSH2 signiﬁcantly increased the target-
ing efﬁciency [Figure 1c, compare green and white bars;
efﬁciencies in wild-type cells were taken from Ref. (26)].
In particular, 4 nt could now efﬁciently be substituted reach-
ing levels of 60% of the levels found in Msh2
 /  cells
[Figure 1c, oligonucleotides 4n, 4M and 4N; efﬁciencies in
Msh2
 /  cells were taken from Ref. (26)]. The performance
of oligonucleotides substituting 3 nt was more variable rang-
ing from 7% (oligonucleotide 3n) to 90% (oligonucleotide
3N) of the efﬁciencies found in Msh2
 /  cells. Substitution
of a single (oligonucleotide 1m) or 2 nt (oligonucleotides
mxm and 2M) modestly improved (Figure 1c, compare
green and white bars), reaching levels of only 2–14% of
the frequencies found in Msh2
 /  cells. We also investigated
whether MSH2 knockdown had a stronger effect in Msh2
+/ 
ES cells than in wild-type ES cells. This was not the case: the
targeting efﬁciencies of oligonucleotides 1m, 4n, 4M and 4N
did not signiﬁcantly differ in both cell types (Figure 1c, com-
pare orange and green bars).
In general, larger stretches of nucleotides could efﬁciently
be substituted in pS-MSH2 transfected wild-type ES
cells, while 1 or 2 nt substitutions were still signiﬁcantly
suppressed. This indicates that transient knockdown of
MSH2 has not fully abrogated MMR activity. Residual
MMR complexes exist that still detect simple mismatches
(1 and 2 nt), while complex mismatches of 4 nt tend to escape
this detection. Recognition of 3 nt mismatches appears to be
dependent on the sequence context as some (3n and 3M) are
well recognized, while another (3N) escaped detection.
Nucleotide insertions in MSH2 knockdown ES cells
Surprisingly, the efﬁciency of 1 or 4 nt insertions was only
marginally improved after transient down regulation of
MSH2 in wild-type and Msh2
+/  ES cells (Figure 2c, green
and orange bars). Oligonucleotides +4–2 and +4–4 performed
signiﬁcantly better after pS-MSH2 transfection compared to
untreated wild-type cells, while the efﬁciency of oligonu-
cleotides +4–1 and +4–3 did not increase. The efﬁciencies
of these 4 nt insertions in pS-MSH2 transfected wild-type
ES cells remained at only 14–18% of the levels found in
Msh2
 /  cells. Insertion of a single base (+1) was hardly
efﬁcient with a frequency of 1% compared to Msh2
 /  cells.
To rule out that the pS-MSH2 vector was stably integrated
after puromycin selection, protein samples were taken of 16
G418-resistant colonies (eight wild-type and eight Msh2
+/ 
ES cell colonies) and immunoblotted for MSH2. All colonies
showed wild-type levels of MSH2 (data not shown). Further-
more, none of these colonies survived in medium supple-
mented with puromycin, indicating that the effects of
pS-MSH2 transfection were truly transient.
Taken together, transient down regulation of MSH2
rendered cells permissive for 4 nt substitutions, but not for
simple nucleotide substitutions or 4 nt insertions, although
these were all highly efﬁcient in Msh2
 /  cells.
Oligonucleotide-mediated targeting in Msh3
 /  and
Msh6
 /  cells
The MSH2/MSH6 heterodimer has been suggested to recog-
nize single base pair mismatches and one or two unpaired
nucleotides, while the MSH2/MSH3 complex is predomi-
nantly involved in the recognition of loops of two to ﬁve
unpaired bases (18,19). In order to study which of these
complexes is responsible for suppression of oligonucleotide-
mediated gene targeting, we have introduced the neo reporter
genes into Msh3
 /  and Msh6
 /  ES cells (21) and studied
the performance of insertion and substitution oligonucleotides
in these cells.
We found that most 4 nt insertions could efﬁciently be
introduced in Msh3
 /  cells (26), but not in Msh6
 /  cells
(Figure 2c, blue bars). This indicates that 4 nt insertions are
mainly suppressed by MSH2/MSH3 complexes. In MSH2
knockdown cells, most 4 nt insertions were less efﬁcient
than in Msh3
 /  cells, indicating that after MSH2 knock-
down, residual MSH2/MSH3 activity was still sufﬁciently
high to suppress 4 nt insertions.
In contrast, nucleotide substitutions were supported by
MSH6 deﬁciency (Figure 1c, blue bars) rather than MSH3
deﬁciency (Figure 1c, red bars). In Msh6
 /  cells, the efﬁci-
ency of nucleotide substitutions was signiﬁcantly increased,
except for oligonucleotide 4M. This indicates that nucleo-
tide substitutions are primarily suppressed by MSH2/MSH6
complexes. Strikingly, simple nucleotide substitutions (1m,
mxm and 2M) and the 3 nt substitutions 3n and 3M were
less efﬁcient in MSH2 knockdown cells than in Msh6
 / 
cells, while complex substitutions (4n, 4M and 4N) and the
3 nt substitution 3N, were more efﬁcient in MSH2 knock-
down cells than in Msh6
 /  cells. These ﬁndings suggest
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ent levels of MSH2/MSH6 activity: low levels are sufﬁcient
for suppression of simple substitutions, while suppression of
4 nt substitutions requires high levels of MSH2/MSH6.
Thus, in pS-MSH2 transfected wild-type cells, residual
levels of both MSH2/MSH3 and MSH2/MSH6 complexes
were still able to suppress nucleotide insertions and simple
substitutions.
Effects of transient MSH2 suppression
To obtain an indication of the level of accumulation of
spontaneous mutations as a result of transient suppression
of MSH2 activity, we assessed the occurrence of frameshift
mutations at simple sequence repeats. For this purpose, we
have used two frameshift reporter constructs consisting of a
neo gene in which the open reading frame was disrupted
by either a (G)10 or a (CA)15C repeat. Polymerase slippage
Table 1. Frameshift mutations at simple sequence repeats
Genotype Number of G418-resistant colonies/10
6 cells
(G)10 repeat
a (CA)15C repeat
b
WT pS 0.75 (±0.0) 83 (±22)
WT pS-MSH2 322 (±36) 159 (±51)
Msh2
+/  pS ND 44 (±13)
Msh2
+/  pS-MSH2 ND 214 (±19)
Msh2
 /  pS 2285 (±1039) 5085 (±1239)
aResults from two independent experiments.
bResults from four independent experiments.
Table 2. Spontaneous mutation frequency at the Hprt locus
Genotype Number of Hprt mutants/10
6 cells
Exp. 1
a Exp. 2
a Exp. 3
a Exp. 4
b
WT pS 0 0 1 0
WT pS-MSH2 0 1 2 2
Msh2
+/  pS 0 2 0 0
Msh2
+/  pS-MSH2 0 1 0 0
Msh2
 /  pS 15 7 5 36
aCells were plated onto 85 cm
2.
bCells were plated onto 300 cm
2.
 
 
 
           
 
(a)
(b)
(c) (d)
Figure 4. Oligonucleotide-mediated codon substitution in Rb.( a) Single-stranded DNA oligonucleotide Rb-CTTT was designed to replace an asparagine by a
phenylalanine at position 750 in exon 22 of the Rb gene. Mismatching bases are indicated in red. Arrows indicate the location of PCR primers. (b) Primer pair 1/2
was used to amplify a 738 bp fragment from pools of cells. This fragment was used in a second PCR round using the nested primer pairs 3/4 or 5/6 of which
primers 3 and 6 are specific for the CTTT mutation. (c) Sequence analysis of Rb mRNA in a purified mutant ES cell clone revealed the presence of the CTTT
mutation, replacing the asparagine at position 750 by a phenylalanine. (d) PCR-based detection of Rb
N750F mutation in genomic DNA. PCRs were conducted
with primer pairs 1/2 and 3/4, yielding a 213-bp product specific for the CTTT mutation. Lane M, molecular mass standards; lane 1, Rb
+/N750F ES cell clone;
lane 2, Rb
+/N750F mouse; lane 3, wild-type littermate; lane 4, water control; * indicates non-specific band.
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may lead to e.g. deletion of a single G or addition of a
CA restoring the open reading frame and resulting in G418
resistance. At the (G)10 repeat, pS-MSH2 transfected wild-
type cells showed a slippage frequency that was  400-fold
higher than in control wild-type cells but 7-fold lower than
in Msh2
 /  cells (Table 1). At the (CA)15C repeat, MSH2
suppression resulted in only a 2-fold increase in slippage
frequency compared to untreated wild-type cells which was
 30-fold lower than in Msh2
 /  cells (Table 1). Similar
results were obtained in Msh2
+/  ES cells, where the slippage
frequency increased 5-fold upon pS-MSH2 transfection,
but was still 25-fold lower compared to Msh2
 /   cells.
In addition, we have determined the mutation frequency at
the Hprt locus, assayed by the appearance of 6-thioguanine
resistant cells. We initially plated cells at a density of 10
6
per 85 cm
2. The number of 6-thioguanine (6TG)-resistant
colonies per 10
6 pS-MSH2 transfected wild-type cells varied
between 0 and 2, whereas one Hprt mutant was found in
untreated wild-type cells (Table 2). In Msh2
+/  cells, the
number of Hprt mutants was not increased upon transient
down regulation of MSH2. To exclude the possibility that
6-TG-resistant colonies are lost due to metabolic co-operation
by wild-type cells, we also plated cells at a density of 10
6
per 300 cm
2. Except for Msh2
 /  cells, this did not lead to
increased numbers of colonies (Table 2, exp. 4). The large
ﬂuctuation in the number of 6-TG-resistant Msh2
 /  colonies
is most likely due to variations in the appearance of the ﬁrst
mutant cell in each culture.
These results indicate that the accumulation of spontane-
ous mutations is increased upon transient disabling of the
MMR machinery but remains well below that in constitutive
MMR-deﬁcient cells.
Oligonucleotide-mediated codon substitution in Rb
Our results indicate that transient suppression of MSH2 activ-
ity allows effective substitution of 4 nt and may be used to
introduce codon substitutions in non-selectable genes. As
an example, we present an oligonucleotide-mediated codon
substitution (N750F) in the retinoblastoma gene Rb.W e
designed a 38-mer oligonucleotide with four centrally located
substitutions in order to replace the asparagine at position
750 by a phenylalanine (Figure 4a). In this experiment, we
used Msh2
+/  cells, although we later realized that wild-
type cells perform equally well (Figure 1c). pS-MSH2-treated
Msh2
+/  ES cells were exposed to oligonucleotide Rb-CTTT
and seeded into four 96-well plates at a density of 5000 cells
per well. Genomic DNA was isolated and a 738 bp product
was ampliﬁed by PCR using primers 1 and 2 (Figure 4a).
Pools containing cells with the oligonucleotide-mediated
modiﬁcation were identiﬁed by a nested mutation-speciﬁc
PCR (Figure 4b). In this second PCR, primers 3/4 or primers
5/6 could only amplify a product when the CTTT mutation
was present. One well was identiﬁed giving a PCR product
with primers 3/4 and primers 5/6. From this positive pool, a
single cell clone was isolated in three subsequent screening
rounds, in which cells were seeded in pools of 100, 10 and 1
cells per well, respectively. The Rb
+/N750F ES cell clone
was veriﬁed by sequencing of mRNA (Figure 4c) and
used for the generation of mouse chimeras. In contrast to
Msh2
 /  ES cells, pS-MSH2 transfected Msh2
+/  cells
were able to contribute to the germ line of chimeric mice.
The Rb
N750F allele was transmitted to their offspring as
indicated by the presence of the 213-bp mutation-speciﬁc
PCR band ampliﬁed from genomic mouse DNA (Figure 4d).
DISCUSSION
The results presented here establish a generally applicable
procedure for the generation of subtle gene modiﬁcations
in mouse ES cells. Oligonucleotide-mediated gene targeting
in combination with a temporary knockdown of the MMR
system allowed effective substitution of 4 nt, which makes
it possible to substitute virtually any codon in any gene.
We have successfully created a codon substitution (N750F)
in the Rb gene of MMR-proﬁcient ES cells and used these
cells to generate mutant mice. The targeting procedure was
cost-effective and rapid: already 2 weeks after oligo-
nucleotide transfection, a single modiﬁed cell could be
identiﬁed in a pool of 5000 unmodiﬁed cells by a mutation-
speciﬁc PCR. This example illustrates the potential power
of oligonucleotide-mediated gene targeting as an effective
novel tool for mouse genetics.
We demonstrated that transient knockdown of MSH2
rendered cells permissive for oligonucleotide-mediated nucle-
otide substitutions. Yet, not all substitutions were equally
efﬁcient: oligonucleotides 3N, 4n, 4M and 4N performed
best with targeting frequencies comparable to those in
Msh2
 /  ES cells (Figure 1c). Interestingly, three of these
oligonucleotides (3N, 4n and 4N) already showed a slightly
higher targeting frequency in untreated wild-type cells than
the other oligonucleotides (26), indicating that the mis-
matches that are created by these oligonucleotides are not
very well recognized by the MMR machinery. On the other
hand, oligonucleotides substituting 1 (1m), 2 (mxm and
2M) or 3 nt (3n and 3M) performed moderately in MSH2
knockdown cells and very poorly in untreated wild-type
cells. This indicates that these mismatches are strongly recog-
nized by the MMR machinery.
We showed that nucleotide substitutions were mainly
suppressed by MSH2/MSH6 complexes, since they were
only efﬁcient in Msh2
 /  and Msh6
 /  ES cells, but not in
Msh3
 /  ES cells (Figure 1c). Remarkably, targeting efﬁcien-
cies in Msh2
 /  cells were  5-fold higher than in Msh6
 / 
cells, suggesting that nucleotide substitutions were also
suppressed by MSH2/MSH3 complexes.
Single or 4 nt insertions were only marginally improved in
MSH2 knockdown cells compared to untreated wild-type
cells. High efﬁciencies in Msh2
 /  and Msh3
 /  ES cells
indicate that nucleotide insertions are primarily suppressed
by MSH2/MSH3 complexes (26). Again, Msh2
 /  cells
showed  2-fold higher efﬁciencies than Msh3
 /  cells,
suggesting a slight suppression of nucleotide insertions by
MSH2/MSH6 complexes.
Transient down regulation of MSH2 resulted in an
increased mutation frequency (Table 1). Yet, we have good
reasons to believe that this should not hamper general
application of our targeting approach. First, simple oligo-
nucleotide-mediated gene modiﬁcations were still
suppressed in pS-MSH2 transfected wild-type cells, indicating
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residual MMR activity as well. Second, temporary knock-
down of MSH2 only modestly affected the slippage
frequency at the (CA)15C reporter (Table 1) and the muta-
tion frequency at the endogenous Hprt gene in both wild-
type and Msh2
+/  cells (Table 2). Only the slippage fre-
quency at the (G)10 reporter was strongly increased
(although still 7-fold lower than in Msh2
 /  cells). This
seems in contrast to the strong suppression of a single nuc-
leotide insertion by oligonucleotide +1 (Figure 2) and may
reﬂect a particularly high sensitivity of the (G)10 reporter
to MMR defects as has been observed in yeast (27,28).
Moreover, poly(G/C) repeats are less abundant than
poly(A/T) tracts and seem to be excluded from the coding
regions of various eukaryotic genomes (29,30). Third, pS-
MSH2-treated Rb
+/N750F ES cells were used to generate chi-
meric mice that were able to transmit the modiﬁed allele
through the mouse germ line, while our constitutively
MSH2-deﬁcient ES cell line did not contribute to the
mouse germ line. Finally, inadvertent mutations that may
have arisen during the brief period of MSH2 down regula-
tion will be crossed out in subsequent generations of mice.
This backcrossing will avoid confounding effects of
unlinked mutations on the phenotype of the oligonucleotide-
mediated modiﬁcation.
We have demonstrated that MMR raises a strong barrier
to successful oligonucleotide-mediated gene targeting in
ES cells. Similar observations have been made in E. coli,
where loss of MMR improved oligonucleotide-mediated
gene targeting by Red-mediated recombination by  100-
fold (12). However, constitutive MMR deﬁciency may lead
to an unacceptably high level of inadvertent spontaneous
mutations. The experiments presented here disclose a dual
approach to circumvent this problem and yet achieve reason-
able targeting frequencies: a temporary down regulation of
MMR activity and the use of oligonucleotides that escape
detection by residual MMR. During the brief period of
MMR disabling, residual mismatch recognition capacity
still largely suppresses spontaneous mutagenesis caused by
simple mismatches. However, complex mismatches are not
recognized allowing effective 4 nt substitutions. We are
now routinely using this procedure to introduce codon substi-
tutions into the germ line of mice. We have targeted three
different loci and found targeting efﬁciencies between 0.25
and 1.5 oligonucleotide-modiﬁed cell per 10
6 cells, which
is comparable to the Rb
+/N750F mutant presented here. Target-
ing efﬁciencies appear to be locus dependent, although
more experiments are needed to conﬁrm this observation.
As we have shown previously, generation of knockout
mice can readily be achieved by 4 nt insertion oligo-
nucleotides in Msh3
 /  ES cells, which are germ line
competent (26).
More insight into the mechanisms of oligonucleotide-
mediated gene targeting may extend its use to in vivo
applications. Stable correction of gene mutations by
chemically modiﬁed oligonucleotides in muscle ﬁbers (31)
and retinas (14) of mice holds great promise for therapeutic
applications. A major advantage of oligonucleotide-mediated
gene targeting is the opportunity of correcting gene mutations
without integration of exogenous DNA, potentiating this
technique for gene therapy strategies and treatment of
human disease.
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